{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:47:35Z","timestamp":1759063655398},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,7]],"date-time":"2013-05-07T00:00:00Z","timestamp":1367884800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0062674","type":"journal-article","created":{"date-parts":[[2013,5,8]],"date-time":"2013-05-08T01:07:45Z","timestamp":1367975265000},"page":"e62674","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Neutralizing Antibodies in Patients with Chronic Hepatitis C, Genotype 1, against a Panel of Genotype 1 Culture Viruses: Lack of Correlation to Treatment Outcome"],"prefix":"10.1371","volume":"8","author":[{"given":"Jannie","family":"Pedersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja B.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas H. R.","family":"Carlsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian","family":"Sch\u00f8nning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peer Brehm","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex Lund","family":"Laursen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Krarup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Bukh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Weis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,5,7]]},"reference":[{"key":"ref1","first-page":"74","article-title":"The global burden of hepatitis C. Liver Int","volume":"29","author":"D Lavanchy","year":"2009"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"MP Manns","year":"2001","journal-title":"Lancet"},{"key":"ref3","first-page":"645","article-title":"Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology","volume":"38","author":"GL Davis","year":"2003"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1056\/NEJMoa1012912","article-title":"Telaprevir for previously untreated chronic hepatitis C virus infection","volume":"364","author":"IM Jacobson","year":"2011","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJMoa1014463","article-title":"Response-guided telaprevir combination treatment for hepatitis C virus infection","volume":"365","author":"KE Sherman","year":"2011","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1010494","article-title":"Boceprevir for untreated chronic HCV genotype 1 infection","volume":"364","author":"F Poordad","year":"2011","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2011.07.016","article-title":"Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan","volume":"56","author":"H Kumada","year":"2012","journal-title":"J Hepatol"},{"key":"ref8","first-page":"1523","article-title":"Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C. Hepatology","volume":"51","author":"G Askarieh","year":"2010"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/hep.24056","article-title":"Quantitation of pretreatment serum interferon-gamma-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response","volume":"53","author":"JM Darling","year":"2011","journal-title":"Hepatology"},{"key":"ref10","first-page":"960","article-title":"Quasispecies as predictive response factors for antiviral treatment in patients with chronic hepatitis C. Dig Dis Sci","volume":"51","author":"J Salmeron","year":"2006"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1111\/j.1365-2893.2010.01392.x","article-title":"Interleukin-28B polymorphisms are associated with hepatitis C virus clearance and viral load in a HIV-1-infected cohort","volume":"18","author":"LN Clausen","year":"2011","journal-title":"J Viral Hepat"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1471-2334-11-177","article-title":"Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: A Danish nationwide cohort study","volume":"11","author":"N Hansen","year":"2011","journal-title":"BMC Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"T Wakita","year":"2005","journal-title":"Nat Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/hep.22673","article-title":"Development and characterization of hepatitis C virus genotype 1\u20137 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs","volume":"49","author":"JM Gottwein","year":"2009","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/593021","article-title":"Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection","volume":"198","author":"TB Jensen","year":"2008","journal-title":"J Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1073\/pnas.0711044105","article-title":"Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization","volume":"105","author":"TK Scheel","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1073\/pnas.0504877103","article-title":"Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras","volume":"103","author":"T Pietschmann","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"BD Lindenbach","year":"2005","journal-title":"Science"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1128\/JVI.01605-10","article-title":"Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations","volume":"85","author":"TK Scheel","year":"2011","journal-title":"J Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1053\/j.gastro.2007.08.005","article-title":"Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a\/2a (S52\/JFH1) viruses","volume":"133","author":"JM Gottwein","year":"2007","journal-title":"Gastroenterology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1128\/JVI.01890-06","article-title":"Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus","volume":"81","author":"M Yi","year":"2007","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1084\/jem.191.9.1499","article-title":"Analysis of successful immune responses in persons infected with hepatitis C virus","volume":"191","author":"F Lechner","year":"2000","journal-title":"J Exp Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI118842","article-title":"Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response","volume":"98","author":"G Missale","year":"1996","journal-title":"J Clin Invest"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/hep.24171","article-title":"In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus","volume":"53","author":"P Meuleman","year":"2011","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"10149","DOI":"10.1073\/pnas.0403519101","article-title":"Neutralizing antibody response during acute and chronic hepatitis C virus infection","volume":"101","author":"C Logvinoff","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","first-page":"6025","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C. Proc Natl Acad Sci U S A","volume":"104","author":"JM Pestka","year":"2007"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/infdis\/jir835","article-title":"Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion","volume":"205","author":"S Raghuraman","year":"2012","journal-title":"J Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1172\/JCI39133","article-title":"Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence","volume":"119","author":"B Rehermann","year":"2009","journal-title":"J Clin Invest"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.gastro.2006.12.008","article-title":"Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo","volume":"132","author":"T von Hahn","year":"2007","journal-title":"Gastroenterology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1053\/j.gastro.2004.09.050","article-title":"Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels","volume":"127","author":"S Zeuzem","year":"2004","journal-title":"Gastroenterology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jcv.2007.04.019","article-title":"Neutralizing antibodies in patients with chronic hepatitis C infection treated with (Peg)-interferon\/ribavirin","volume":"39","author":"I Boo","year":"2007","journal-title":"J Clin Virol"},{"key":"ref32","first-page":"E60","article-title":"Analysis of neutralizing antibodies against hepatitis C virus in patients who were treated with pegylated-interferon plus ribavirin","volume":"56","author":"M Sasayama","year":"2010","journal-title":"Kobe J Med Sci"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/00365540600978864","article-title":"Liver biopsy performance and histological findings among patients with chronic viral hepatitis: a Danish database study","volume":"39","author":"PB Christensen","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2893.2009.01126.x","article-title":"Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort study","volume":"16","author":"N Hansen","year":"2009","journal-title":"J Viral Hepat"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1128\/JCM.41.3.1091-1100.2003","article-title":"Hepatitis C virus subtyping by a core-envelope 1-based reverse transcriptase PCR assay with sequencing and its use in determining subtype distribution among Danish patients","volume":"41","author":"S Corbet","year":"2003","journal-title":"J Clin Microbiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1099\/vir.0.018929-0","article-title":"Hepatitis C virus superinfection of liver grafts: a detailed analysis of early exclusion of non-dominant virus strains","volume":"91","author":"S Ramirez","year":"2010","journal-title":"J Gen Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1128\/JVI.02667-09","article-title":"Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studies","volume":"84","author":"JM Gottwein","year":"2010","journal-title":"J Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.01594-10","article-title":"Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization","volume":"85","author":"J Prentoe","year":"2011","journal-title":"J Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"8217","DOI":"10.1128\/JVI.79.13.8217-8229.2005","article-title":"An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies","volume":"79","author":"B Bartosch","year":"2005","journal-title":"J Virol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1073\/pnas.0501275102","article-title":"Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1","volume":"102","author":"JC Meunier","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1128\/JVI.01941-12","article-title":"Cooperativity in virus neutralization by human monoclonal antibodies to two adjacent regions located at the amino terminus of hepatitis C virus e2 glycoprotein","volume":"87","author":"Z Keck","year":"2013","journal-title":"J Virol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e1002653","DOI":"10.1371\/journal.ppat.1002653","article-title":"Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate","volume":"8","author":"ZY Keck","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"9499","DOI":"10.1073\/pnas.1202924109","article-title":"Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1","volume":"109","author":"L Kong","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1182\/blood.V98.9.2657","article-title":"A 385 insertion in the hypervariable region 1 of hepatitis C virus E2 envelope protein is found in some patients with mixed cryoglobulinemia type 2","volume":"98","author":"M Gerotto","year":"2001","journal-title":"Blood"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF01311170","article-title":"Sequence variability in the env-coding region of hepatitis C virus isolated from patients infected during a single source outbreak","volume":"137","author":"M Hohne","year":"1994","journal-title":"Arch Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1073\/pnas.1114927109","article-title":"Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus","volume":"109","author":"E Giang","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"8101","DOI":"10.1128\/JVI.00127-07","article-title":"The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein","volume":"81","author":"F Helle","year":"2007","journal-title":"J Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nm1698","article-title":"Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge","volume":"14","author":"M Law","year":"2008","journal-title":"Nat Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1073\/pnas.0902749106","article-title":"Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity","volume":"106","author":"P Zhang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.gastro.2012.04.006","article-title":"Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies","volume":"143","author":"I Fofana","year":"2012","journal-title":"Gastroenterology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1086\/314653","article-title":"Experimental transmission of hepatitis C virus-associated fulminant hepatitis to a chimpanzee","volume":"179","author":"P Farci","year":"1999","journal-title":"J Infect Dis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.277.5325.570","article-title":"Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA","volume":"277","author":"AA Kolykhalov","year":"1997","journal-title":"Science"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1053\/jhep.2001.27831","article-title":"Estimating progression to cirrhosis in chronic hepatitis C virus infection","volume":"34","author":"AJ Freeman","year":"2001","journal-title":"Hepatology"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1128\/JVI.02265-09","article-title":"Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection","volume":"84","author":"L Liu","year":"2010","journal-title":"J Virol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0062674","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T05:43:18Z","timestamp":1540014198000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0062674"}},"subtitle":[],"editor":[{"given":"Birke","family":"Bartosch","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,7]]},"references-count":54,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0062674","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,7]]}}}